ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,863Medicare Part D Prescriptions Filled, Including Refills

Rank: 48 out of 1269

$581K Total Retail Price of All Prescriptions

Rank: 102 out of 1269

306 Patients Receiving at Least One Drug in Part D
96%Patients 65 Years and Older
92% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maryland
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 306 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

4% of this provider’s 306 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

0% of this provider’s 11,347 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

39 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maryland
LISINOPRIL 491 490 1 1
FUROSEMIDE 490 490 2 5
LEVOTHYROXINE SODIUM 488 477 3 4
OMEPRAZOLE 409 382 4 8
POLYETHYLENE GLYCOL 3350 371 365 5 50
SIMVASTATIN 356 332 6 3
AMLODIPINE BESYLATE 343 342 7 2
MIRTAZAPINE 326 311 8 24
ESCITALOPRAM OXALATE 312 300 9 58
METOPROLOL TARTRATE 307 307 10 6
POTASSIUM CHLORIDE 281 263 11 26
SERTRALINE HCL 276 253 12 23
WARFARIN SODIUM 276 267 12 12
TRAMADOL HCL 249 240 14 16
DONEPEZIL HCL 238 238 15 22
LEXAPRO 175 167 16 174
METOPROLOL SUCCINATE 174 174 17 13
QUETIAPINE FUMARATE 165 135 18 53
ATENOLOL 147 147 19 14
DIOVAN 144 144 20 35
KLOR-CON M20 141 141 21 60
LIDODERM 137 137 22 56
CITALOPRAM HBR 130 130 23 21
CARBIDOPA-LEVODOPA 122 122 24 78
RISPERIDONE 111 111 25 43
LANTUS 111 80 25 39
GABAPENTIN 110 110 27 17
LEVETIRACETAM 107 83 28 55
NAMENDA 102 102 29 38
LOSARTAN POTASSIUM 96 96 30 15
TRAVATAN Z 86 86 31 187
LANTUS SOLOSTAR 82 79 32 144
PREDNISONE 81 81 33 45
BRIMONIDINE TARTRATE 78 78 34 205
ALENDRONATE SODIUM 76 76 35 28
ATORVASTATIN CALCIUM 75 73 36 7
SPIRIVA 73 73 37 64
FLUTICASONE PROPIONATE 68 68 38 40
ALLOPURINOL 68 54 38 49
TRAZODONE HCL 67 65 40 36
NYSTATIN 67 44 40 119
GLIMEPIRIDE 64 49 42 57
NITROGLYCERIN PATCH 63 63 43 114
CYMBALTA 62 61 44 70
TAMSULOSIN HCL 62 62 44 31
SEROQUEL 61 55 46 104
FAMOTIDINE 60 60 47 85
PLAVIX 60 48 47 47
ZOLPIDEM TARTRATE 60 60 47 19
LATANOPROST 59 59 50 143
OLANZAPINE 59 59 50 89
FENTANYL 56 56 S2 52 105
DIGOXIN 53 53 53 62
OXYCODONE-ACETAMINOPHEN 53 53 S2 53 44
HYDROCODONE-ACETAMINOPHEN 52 52 S3 55 20
CARVEDILOL 52 52 55 29
NOVOLOG 50 26 57 82
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.